US · medical devices · pulmonary embolism · thrombectomy
Who invested in Endovascular Engineering, Inc. (“E2”)
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
1
rounds observed
7
investors named
$80M
reported across those rounds
Apr 2026
most recent
The rounds
Series C · Apr 2026 · $80M
Norwest lead, Gilde Healthcare lead, S3 Ventures, Santé Ventures, 415 Capital, M&L Healthcare Investments, Panakès Partners
Reported by Ventureburn
Everyone who backed them
InvestorTypeRounds
Missing a round, or an investor who was in one? Tell us.